The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Adequan 250 mg/ml Solution for Injection

Daiichi Sankyo Altkirch SARLVPA10404/001/002

Main Information

Trade NameAdequan 250 mg/ml Solution for Injection
Active SubstancesGlycosaminoglycan polysulfate
Dosage FormSolution for injection
Licence HolderDaiichi Sankyo Altkirch SARL
License Holder Address39 rue de 3-eme Zouaves, BP 60005
Altkirch Cedex
Licence NumberVPA10404/001/002

Group Information

ATC CodeQM01AX12 glucosaminoglycan polysulfate
Therapeutic ClassMiscellaneous


License statusAuthorised
Licence Issued02/07/2010
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation


Summary of Product Characteristics *PDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
VariationsNo document available

* The PDF document, together with the national-specific product information on this page, constitute the authorised SPC
« Back